Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

RATAF -RATe Control in Atrial Fibrillation.

Trial Profile

RATAF -RATe Control in Atrial Fibrillation.

Phase of Trial: Phase III

Latest Information Update: 07 Nov 2012

At a glance

  • Drugs Carvedilol (Primary) ; Diltiazem (Primary) ; Metoprolol (Primary) ; Verapamil (Primary)
  • Indications Atrial fibrillation
  • Focus Biomarker; Pharmacodynamics; Therapeutic Use
  • Acronyms RATAF
  • Most Recent Events

    • 07 Nov 2012 Results presented at the 85th Annual Scientific Sessions of the American Heart Association.
    • 29 Aug 2012 Results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.
    • 29 Aug 2012 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top